(HealthDay)—Efpeglenatide once weekly leads to dose-dependent reductions in glucose and body weight in patients with early type 2 diabetes, according to a phase 2 study published online July 18 in Diabetes Care.
Aug 5, 2019
0
2
(HealthDay)—Older age, cardiovascular comorbidities, and renal complications increase the risk for atrial fibrillation (AF) in patients with type 1 diabetes, according to a study published online June 6 in Diabetes Care.
Jun 20, 2019
0
0
(HealthDay)—Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older, the U.S. Food and Drug Administration announced yesterday.
Jun 18, 2019
0
4
Pregnant women with type 1 diabetes are at increased risk of delivering their baby prematurely. The risk increases as blood sugar levels rise, however women who maintain the recommended levels also risk giving birth prematurely. ...
Apr 25, 2019
0
6
New research updates guidance to clinicians on how best to treat patients with type 2 diabetes who do not respond to glucose-lowering medication.
Apr 12, 2019
0
5
(HealthDay)—Rates of diabetes screening are high, with hemoglobin A1c (HbA1c) used less but more likely to result in clinical diagnosis, according to a study published online Feb. 6 in Diabetes Care.
Feb 11, 2019
0
0
(HealthDay)—Ensuring a short duration between dinner and bedtime has no effect on hemoglobin A1c (HbA1c) levels in middle-aged and older Japanese adults, according to a study published online Jan. 22 in BMJ Nutrition, Prevention ...
Jan 24, 2019
0
3
A new study has shown that only a minority of patients in the U.S. with type 1 diabetes (T1D) achieve target levels of hemoglobin A1c, a measure of blood glucose management over time. In fact HbA1c levels have increased in ...
Jan 22, 2019
0
0
Leaving a two-hour gap between the last meal of the day and bedtime doesn't seem to be associated with any discernible difference in blood glucose levels among healthy adults over the long term, suggests Japanese research ...
Jan 21, 2019
0
4
Treatment of the autoimmune disease type 1 diabetes in Germany depends on where the patients live in. In socio-economically weaker regions, insulin pumps and long-acting insulin analogs are used less frequently. Here, the ...
Nov 30, 2018
0
2
